Threonine

Threonine

SCHEMBL15322931

CC(=O)OC(=O)[C@@H](N)CCCNC(=N)N.C[C@@H](O)[C@H](N)C(=O)O.C[N+](C)(C)CCO

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Threonine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 2/20 0.32
▸ NPY1R P25929 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL15324499 0.88 OTC (0.38) NPY4RNPY1R
Arginine SCHEMBL15322928 0.87 OTC (0.35) NPY4RNPY1R
Threonine SCHEMBL285577 0.82 NPY4R (0.36) NPY4RNPY1R
Arginine SCHEMBL15322472 0.81 OTC (0.39) NPY4RNPY1R
Arginine SCHEMBL15322527 0.80 OTC (0.42) —
Arginine SCHEMBL15322526 0.80 OTC (0.42) —
Arginine SCHEMBL7929056 0.80 OTC (0.43) —
Arginine SCHEMBL30517755 0.80 OTC (0.43) —
SCHEMBL25300066 0.80 NPY4R (0.39) NPY4RNPY1R
SCHEMBL446930 0.80 NPY4R (0.39) NPY4RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2836832-A1 EARLY TRIMESTER SCREENING FOR EARLY- AND LATE-ONSET PREECLAMPSIA Wayne State University (US) 2015-02-18 — — EP disclosed
WO-2013155458-A1 EARLY TRIMESTER SCREENING FOR EARLY- AND LATE-ONSET PREECLAMPSIA WAYNE STATE UNIVERSITY (US) 2013-10-17 — — WO disclosed
Send feedback